Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01745354
Title Immunostimulatory CpG SD-101 + RT in Recurrent/Progressive Lymphoma After Allogeneic Hematopoietic Cell Transplantation (HCT)
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Robert Lowsky
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Stanford University School of Medicine Palo Alto California 94305 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field